They additional they hope the a lot easier entry to Zepbound will discourage folks from using untested, knock-off medications to deal with obesity.Deep Dive Biotech’s M&A outlook is uncertain. Track the promotions that happen to be going on here. Billion-dollar biotech buyouts have become rarer. Only 6 of your acquisitions tracked by BioPharma Di